ImmunityBio (26CA) Q4 2022 Earnings Report
DE:26CA Q4 2022 EPS Results
- Actual EPS
- -EUR 0.24
- Consensus EPS
- -EUR 0.20
- Beat/Miss
- Missed by -EUR 0.04
- One Year Ago EPS
- -EUR 0.21
DE:26CA Q4 2022 Revenue Results
- Actual Revenue
- EUR 65.27K
- Expected Revenue
- EUR 22.35K
- Beat/Miss
- Beat by +EUR 42.92K
- YoY Revenue Growth
- -81.28%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 02/28/2023
- Time
- TBA
- Conference Call
- Tuesday, February 28, 2023
DE:26CA Upcoming Earnings
ImmunityBio's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q4 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:26CA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.06- | -0.06 | ― | ― |
| Aug 04, 2026 | 2026 (Q2) | -0.07-0.20 | -0.09 | -120.00% (-0.11) | |
| May 07, 2026 | 2026 (Q1) | -0.06-0.55 | -0.13 | -313.33% (-0.42) | |
| Mar 03, 2026 | 2025 (Q4) | -0.07-0.05 | -0.08 | 33.33% (+0.03) | |
| Nov 04, 2025 | 2025 (Q3) | -0.10-0.06 | -0.13 | 50.00% (+0.06) | |
| Aug 05, 2025 | 2025 (Q2) | -0.10-0.09 | -0.18 | 50.00% (+0.09) | |
| May 12, 2025 | 2025 (Q1) | -0.11-0.13 | -0.18 | 25.00% (+0.04) | |
| Mar 03, 2025 | 2024 (Q4) | -0.18-0.08 | -0.32 | 75.00% (+0.24) | |
| Nov 12, 2024 | 2024 (Q3) | -0.16-0.13 | -0.17 | 26.32% (+0.04) | |
| Aug 09, 2023 | 2023 (Q2) | -0.21-0.28 | -0.21 | -31.25% (-0.07) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
